姜燕荣教授、主任医师、博士研究生导师，现任北京大学人民医院眼科中心副主任，中国女医师协会眼科专委会付主任委员兼秘书长。近年来先后承担完成国家自然科学基金等资助的科研项目多项；以第一作者及通讯作者发表有关学术论文百余篇，其中SCI论文近30篇，参与编写专著4部，获得国家发明专利及实用新型专利6项；2012年作为第一获奖人，以项目“视网膜血管性疾病的基础研究及临床应用”获高等学校科学研究优秀成果奖（科学技术）科技进步一等奖。
以通讯作者发表的SCI论文：
1．Yong Tao，Yanrong Jiang，Xiaoxin Li.Fundus and Histopathological Study of Radial Optic Neurotomy in the Normal Miniature Pig Eye.Arch Ophthalmol.2005;123:1097-1101.
2．Kai Wang，Yanrong Jiang，Xiaoxin Li.Vehicle of Triamcinolone Acetonide is Associated with Retinal Toxicity and Transient Increase of Lens Density . Graefes Arch Clin Exp Ophthalmol  2006；244（9）：1152-1159.
3．Kai W, YR Jiang . Reply to the comment by P.E. Carvounis and E.R. Holz "Vehicle of triamcinolone acetonide is associated with retinal toxicity and transient increase of lens density". Graefes Arch Clin Exp Ophthalmol. 2007;245:181-182.
4.  Hou J, Tao Y, Jiang YR, Wang K. In vivo and In vitro Study of Suprachoroidal Fibrin Glue. Jpn J Ophthalmol 2009;53:640–647.
5． Hou J, Tao Y, Jiang YR, Li XX, Gao L. Intravitreal Bevacizumab versus Triamcinolone  Acetonide for Macular Edema Due to Branch Retinal Vein Occlusion: A Matched Study. Chin Med J.2009;122(22):2695-2699.
6.  Kai Wang, Yanrong Jiang .Axial length and anterior chamber depth measurements before and after removal of silicone oil: correction of axial length of silicone-filled eyes for optical biometry. Ophthalmic Physiol Opt 2009;29(4):449-57.
7.  Yanrong Jiang ,Xiaoying liang “Analysis of the Clinical Efficacy of Intravitreal Bevacizumab in the Treatment of Iris Neovascularization caused by Proliferative Diabetic Retinopathy” Acta Ophthalmol. 2009: 87: 736–740.
8.      Tao Y, Hou J, Jiang YR, Li XX, Jonas JB. Intravitreal bevacizumab vs triamcinolone acetonide for macular oedema due to central retinal vein occlusion. Eye (Lond). 2010;24(5):810-5.
 9.  Tao Y, Jiang YR, Li XX, Gao L, Jonas JB. Long-term results of vitrectomy without
endotamponade in proliferative diabetic retinopathy with tractional retinal detachment. Retina. 2010;30(3):447-51.
10.   Tao Y, Lu Q, Jiang YR, Qian J, Wang JY, Gao L, Jonas JB. Apelin in plasma and vitreous and in fibrovascular retinal membranes from patients with proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci （IOVS）2010;51:4237–4242.
11. Qian J，Jiang YR. Anatomical evaluation of macular holes with silicone oil tamponades in highly myopic eyes using optical coherence tomography. European Journal of Ophthalmology. 2010 Sep-Oct;20(5):938-44.
12. Yuan MK,Tao Y，Yu WZh,W K, Jiang YR.Lentivirus-mediated RNA Interference of Vascular Endothelial Growth Factor in Monkey Eyes with Iris Neovascularization . Molecular Vision 2010;16:1743-1753.
13. Yanrong Jiang ,Peng Zhou“Long Term Follow Up of Local Relaxing Vitrectomy for Stage 4 Retinopathy of Prematurity”Ophthalmic Surgery, Lasers and Imaging 2010 Vol. 41 e1–3.
14. Jiang YR, Tao Y, Jonas JB. Traumatic choriodialysis treated by intraocular fibrin glue. Acta Ophthalmol. Acta Ophthalmol. 2010;88(4):e129-30.
15.   Qian J,Lu Q，Tao Y，Jiang YR,Vitreous and Plasma Concentrations of apelin and Vascular Endothelial Growth Factor after Intravitreal Bevacizumab in Eyes with Proliferative Diabetic Retinopathy. Retina 2011; 31:161–168.
16. Tong Zhao, Kai Wang, Yan Ma, Yan-Rong Jiang, Resolution of total retinal detachment in Coats'       
disease with intravitreal injection of bevacizumab. Graefes Arch Clin Exp Ophthalmol.2011;  249:1745–1746.
17. Wang JY, Lu Q, Tao Y, Jiang YR, Jonas JB. Intraocular expression of thymosin β4 in proliferative diabetic retinopathy. Acta Ophthalmol..2011;89(5):e396-403. 
18. Jing Qian,, Yan-Rong Jiang, Decreased Prothrombin Time after Intravitreal Bevacizumab in the Early Period in Patients with Proliferative Diabetic Retinopathy. Acta Ophthalmol.. 2011: 89: e332–e335.
19. Tong Zhao, Qiang Lu,Yong Tao, Xiaoying Liang，Kai Wang, Yan-Rong Jiang , A Preliminary Study of Apelin and VEGF after Intravitreal Injection of Bevacizumab in Primate Eyes of Central Retinal Vein Occlusion. Molecular Vision .2011; 17:1044-1055.
20. Yan Ma,,Qiang Lu,Yong Tao, Yan-Rong Jiang ,Intraocular Expression of Serum Amyloid A and Interleukin-6 in Proliferative Diabetic Retinopathy. Am J Ophthalmol 2011;152:678–685.
21. Ma Y, Jiang YR.Vitreous and plasma levels of vascular endothelial growth factor after injection bevacizumab in proliferative diabetic retinopathy eyes. Am J Ophthalmol 2012 ;153(2):307-313.
23. Wang XL, Tao Y, Lu Q, Jiang YR .Apelin Supports Primary Rat Retinal Müller Cells under Chemical Hypoxia and Glucose Deprivation Peptides. 2012；（33）：298–306.
24. Jiao J, Mo B, Wei H, Jiang YR.Comparative study of laser-induced choroidal neovascularization in rats by paraffin sections, frozen sections and high-resolution optical coherence tomography. Graefes Arch Clin Exp Ophthalmol. 2013 Jan;251(1):301-7.
25. Yong Tao，Jiang YR .Evaluation of An in-situ Chemically Crosslinked Hydrogel as a Long-term Vitreous Substitute Material. ACTA BIOMATER 2013;9(2)：5022—5030.